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Abstract
This paper introduces new effect parameters for factorial survival designs with possibly right-censored time-to-event data.
In the special case of a two-sample design it coincides with the concordance or Wilcoxon parameter in survival analysis.
More generally, the new parameters describe treatment or interaction effects and we develop estimates and tests to infer
their presence. We rigorously study the asymptotic properties by means of empirical process techniques and additionally
suggest wild bootstrapping for a consistent and distribution-free application of the inference procedures. The small
sample performance is discussed based on simulation results. The practical usefulness of the developed methodology is
exemplified on a data example about patients with colon cancer by conducting one- and two-factorial analyses.
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1 Motivation and Introduction
Many biomedical and clinical trials are planned as factorial designs. Here, not only the (main) effects of separate factors
but also interaction effects that are related to possibly complex factor combinations are of importance. Such interaction
effects may even alter the interpretation of main effects leading to the established comment by Lubsen and Pocock (1994)
that ‘it is desirable for reports of factorial trials to include estimates of the interaction between the treatments’.
On the other hand, nonparametric estimation and the inference of adequate effects in such designs can be rather
involved. In particular, most existing inference procedures have focused on testing hypotheses formulated in terms of
distribution functions (Brunner et al., 1997; Brunner and Puri, 2001; Gao and Alvo, 2005, 2008; Gao et al., 2008; Akritas,
2011; Dutta and Datta, 2016; Friedrich et al., 2017; Umlauft et al., 2017a) which cannot be inverted to obtain confidence
intervals or regions for meaningful effects. Only recently, nonparametric methods for inferring adequate effects in general
factorial designs with independent and dependent observations have been established (Konietschke et al., 2016; Brunner
et al., 2017; Umlauft et al., 2017b; Dobler et al., 2018). These procedures are, however, only developed for completely
observed data and not applicable for partially observed time-to-event data. Since many clinical studies are concerned with
survival outcomes, adequate statistical inference methods for complex factorial time-to-event designs are of particular
interest.
To detect main effects, weighted logrank tests or their extensions may be applied in case of two or multiple samples
(Mantel, 1966; Andersen et al., 1993; Ehm et al., 1995; Liu and Dahlberg, 1995; Janssen and Neuhaus, 1997; Bathke
et al., 2009; Yang and Prentice, 2010; Fleming and Harrington, 2011; Brendel et al., 2014). However, these procedures
only infer conclusions in terms of cumulative hazard functions and cannot be applied to obtain concrete effect parameters
with informative confidence intervals nor tests for the presence of interactions. In practice, interaction effects are usually
modeled with the help of Cox-, Aalen- or even Cox-Aalen regression models (Cox, 1972; Scheike and Zhang, 2002, 2003)
with factors as covariates and incorporated interaction terms. However, although very flexible, these models are usually
more driven towards hazards modeling by continuous covariates while the incorporation of several factor variables (e.g.,
via multiple dummy variables per factor) can become cumbersome; especially when interactions are incorporated, see
also Green et al. (2002) and Green (2012) for the uncensored case.
The above problems directly motivate a nonparametric approach for estimating and inferring main and interaction
effects in factorial designs with censored observations. So far, the only existing methods in this context are given by
the nonparametric survival procedures of Akritas and Brunner (1997) and Akritas (2011). They are based on a purely
nonparametric model that does not require any multiplicative or additive structure of the hazards and can even be applied
for arbitrary, possibly non-continuous survival distributions (i.e., it can be readily used for survival times rounded to
days, weeks or months). Moreover, it leads to tests for main and interaction effects in case of independent right-censored
data. However, these tests suffer from several drawbacks: the procedure is based on a rather strong assumption on the
underlying censorship distribution which is often hard to verify in practical situations. In addition, null hypotheses are
only formulated in terms of distribution functions. As a result, there is no direct quantification and estimation of main and
interaction effects in terms of confidence intervals as, e.g., required by regulatory authorities (ICH E9 Guideline, 1998, p.
25).
This is to be changed in the current paper. We develop and rigorously analyze nonparametric inference procedures,
i.e. tests and confidence intervals, for meaningful effect sizes in factorial survival designs, where data may be subject to
random right-censoring.
Similar to the adaption of the Brunner and Munzel (2000) test to the two-sample survival set-up by Dobler and Pauly
(2017), we consider the recently proposed unweighted nonparametric effects of Brunner et al. (2017) and extend their
ansatz to a general survival setting. In the special case of proportional hazards, these effects have a direct relationship
to hazard ratios in two-sample settings (Bru¨ckner and Brannath, 2017) while they remain meaningful in case of non-
proportional hazards. This fact makes the effect sizes even more appealing for practical purposes.
The paper is organized as follows. The statistical model and important results on the basic estimators are presented in
Section 2. The resulting test statistic for the null hypotheses of interest is stated and mathematically analyzed in Section 3.
Since the asymptotic distribution of the test statistic depends on unknown parameters, we propose a distribution-free
multiplier resampling approach in Section 4 and prove its consistency. In Section 5 it is supplemented by a simulation
study to assess the finite sample properties of the proposed procedure. They are then exemplified on a colon cancer study
in Section 6, where in the original study (Moertel et al., 1990) the analysis was made in terms of Cox models. Finally, the
paper closes with concluding comments in Section 7. All proofs are deferred to the technical Appendix.
2 The set-up
To establish the general model, we consider sequences of mutually independent random variables
Tik
ind„ Si and Cik ind„ Gi pi “ 1, . . . , d, k “ 1, . . . , niq, (1)
where Tik denotes the actual survival time of subject k in group i andCik the corresponding censoring variable. Moreover,
to even allow for ties or survival times rounded to weeks or months, the survival functions Si and Gi, i “ 1, . . . , d,
2
defined on p0,8q may be possibly discontinuous. That is, the corresponding hazard rates may, but need not exist. The
actually observable data consist of the right-censored survival times Xik “ Tik ^ Cik and the uncensoring indicators
δik “ 1tTik ď Ciku, i “ 1, . . . , d, k “ 1, . . . , ni. In this set-up, a factorial structure can be incorporated by splitting up
indices, see Section 5 for details.
In the special case of d “ 2 groups with continuous survival times Efron (1967) introduced an estimator for the
concordance probability
w “ P pT11 ą T21q “ ´
ż
S1dS2
that a randomly chosen subject from the first group survives longer than someone from the second group. If all subjects
are completely observable, this effect size w reduces to the well-known Mann-Whitney effect underlying the Brunner
and Munzel (2000) test. Inference procedures for w and related quantities in survival set-ups (such as the concordance
parameter or the average hazard ratio) have, e.g. been developed by Bru¨ckner and Brannath (2017); Dobler and Pauly
(2017). However, an extension of the definition of w to the more general design (1), allowing for an arbitrary factorial
structure, is not straightforward. In particular, for the case of completely observed data, Brunner et al. (2017) and Brunner
et al. (2018) point out several pitfalls that may lead to paradoxical results when working with a ‘wrong’ extension of w.
Adopting their solution to the present situation, we introduce an additional ‘benchmark’ survival time Z, independent of
the above, with averaged survival function Z „ S¯ “ 1d
řd
i“1 Si. This is used to extend w to
p˜i “ P pTi1 ą Zq ` 1
2
P pTi1 “ Zq “ ´
ż
S˘i dS¯,
where the superscript ˘ denotes the average of a right-continuous function and its left-continuous version. The use of
such normalized survival functions adequately handles discrete components of the survival distribution, i.e. ties in the data
are explicitly allowed.
The choice of the effect parameter p˜i is motivated by recent findings on nonparametric analyses of factorial designs
with complete observations in Brunner et al. (2017, 2018). They stress that other choices, e.g. pairwise-comparisons of all
concordance probabilitiesw or comparisons with the weighted survival function
řd
i“1
ni
N Si instead of S¯, may easily result
in paradoxical outcomes. This is no issue for the effects p˜i which are sample size independent. For later calculations, we
emphasize that the effect parameters are balanced in the mean. In particular, we have
1
d
dÿ
i“1
p˜i “ ´
ż
S¯˘dS¯ “ 1
2
and p˜i “ ´
dÿ
j“1
j‰i
ż
S˘i dSj `
1
2d
.
From a practical point of view, estimation of the p˜i’s would need ’arbitrarily’ large survival times since the integral is
defined on p0,8q. However, every study ends at a certain point in time. For practical applicability, we therefore assume
that the censoring times are bounded and we have to modify the p˜i’s accordingly: denote by τ ą 0 the largest possible
censoring time. In comparisons of survival times, which belong to different groups and which exceed τ , no group shall be
favored. In other words, the remaining mass has to be split up equally among the groups. Technically, this is realized by
setting the remaining mass of the survival functions to zero: Sipτq “ 0. Redefining Si and S¯ from now on as the survival
functions of minpTi1, τq and minpZ, τq, respectively, this translates into the nonparametric concordance effects
pi “ P pminpTi1, τq ą minpZ, τqq ` 1
2
P pminpTi1, τq “ minpZ, τqq “ ´
ż
S˘i dS¯. (2)
Obviously, all of the above-discussed positive properties of the effects parameter p˜i also transfer to the nonparametric
concordance effects pi: it is a meaningful effect measure for ordinal and metric data, sample size independent, and allows
for a suitable treatment of ties.
We aggregate all effects into the vector p “ pp1, . . . , pdq1 and borrow a trick from Konietschke et al. and Brunner
et al. (2017) to express them as
p “
´
Id b 1
d
11d
¯
¨ pw11, . . . ,w1dq1 “: Ed ¨ w. (3)
Here, wi “ pw1i, . . . , wdiq1 “ ´
ş
S˘i dS is the Rd-vector of effects for direct comparisons of group i with respect to all
groups j “ 1, . . . , d, and S “ pS1, . . . , Sdq1 is the aggregation of all survival functions. Moreover, Id denotes the identity
matrix in Rd, 1d the d-dimensional vector of 1’s and the symbol b denotes the Kronecker product. In this way the ith
entry of wi is wii “ 12 which makes sense because equal groups should be valued equally high. Anyhow, Equation (3)
shows that the problem of estimating p reduces to the estimation of the pair-wise effects wji. But this can be achieved by
substituting each involved survival function Si by its Kaplan-Meier estimator pSi, i “ 1, . . . , d (Kaplan and Meier, 1958).
Proceeding in this way we denote by pw and pwi these estimated counterparts of w and wi. Let N “ řdi“1 ni be the total
sample size. Below we establish the asymptotic normality of
?
Nppw´ wq under the following framework:
N´1n :“
´n1
N
, . . . ,
nd
N
¯1 Ñ λ :“ pλ1, . . . , λdq1 P p0, 1qd (4)
3
as minn Ñ 8. To give a detailed description of the resulting asymptotic covariance structure, however, we first have
to introduce some additional notation: Let Dr0, τ s be the space of all ca`dla`g-functions on r0, τ s, equipped with the
Skorokhod metric, and BV r0, τ s Ă Dr0, τ s its subspace of ca`dla`g-functions with bounded variation. For the subsequent
arguments it is essential that we can represent w “ φ ˝ S as a functional of S. In particular, the functional
φ : pBV r0, τ sqd Ñ Rd2 , pf1, . . . , fdq1 ÞÝÑ
´
´
ż
f˘i dfj
¯d
i,j“1
,
with inner index j, is Hadamard-differentiable at S; see the proof of Lemma 1 below for details. We denote its Hadamard-
derivative at S by dφS, which is a continuous linear functional. For technical reasons, we assume throughout that P pTi1 ą
τq ą 0 for all groups i “ 1, . . . , d. We may now state the first preliminary but essential convergence result.
Lemma 1. Under the asymptotic regime (4) we have
?
Nppw´ wq dÝÑ W,
where W has a centered multivariate normal distribution on Rd2 .
In particular, we can write W “ dφS ¨diagpλq´1{2U, where U consists of independent, zero-mean Gaussian processes
U1, . . . , Ud with covariance functions
Γipr, sq “ SiprqSipsq
ż r^s
0
dΛi
Si´Gi´p1´∆Λiq , i “ 1, . . . , d,
where Λi denotes the cumulative hazard function corresponding to Si “ Pp1´dΛiq, i “ 1, . . . , d; the symbolP denotes
the product integral (Gill and Johansen, 1990). Here, a minus sign in a subscript indicates the left-continuous version of a
function and ∆Λ “ Λ´Λ´ is the jump size function of Λ. Note that the covariance matrix of W is singular; in particular,
pdφS ¨ diagpλq´1{2Uqi,i “ 0 for all i “ 1, . . . , d. The other entries (i ‰ j) are distributed as follows:
pdφS ¨ diagpλq´1{2Uqi,j “ 1?
λi
ż
U˘i dSj ´
1a
λj
ż
U˘j dSi „ N
´
0,
1
λi
ż ż
Γ˘˘i dSjdSj `
1
λj
ż ż
Γ˘˘j dSidSi
¯
.
Here, the double appearance of ˘ signs means the average of all four combinations of left- and right- continuous versions
in both arguments of a two-parameter function.
Let us now turn to the estimation of the nonparametric concordance effects p. A matrix multiplication of pw with Ed
from the left is basically the same as taking the mean with respect to the inner index j. This immediately brings us to the
first main result:
Theorem 1. Under the asymptotic regime (4) we have
?
Npp´ pq :“ ?NEdppw´ wq dÝÑ EdW “ ´1
d
dÿ
i“1
1?
λi
ż
U˘i dSj ´
1a
λj
ż
U˘j dS¯
¯d
j“1
,
where EdW has the variance-covariance matrix V with the following entries:
Vii “ 1
λi
ż ż
Γ˘˘i dS¯d
´
S¯ ´ 2
d
Si
¯
` 1
d2
dÿ
j“1
1
λj
ż ż
Γ˘˘j dSidSi
in the ith diagonal entry, i “ 1, . . . , d, and
Vij “ 1
d2
dÿ
j“1
1
λj
ż ż
Γ˘˘j dSidSj ´
1
d
1
λi
ż ż
Γ˘˘i dS¯dSj ´
1
d
1
λj
ż ż
Γ˘˘j dS¯dSi
in the off-diagonal entries pi, jq, i ‰ j.
A more compact form of the matrix V is given in Appendix B.
3 Choice of Test Statistic
In order to develop hypothesis tests based on the estimator p, we next need to find a consistent estimator pVN for V. A
natural choice is to plug in estimators for all unknown quantities that are involved in V. In particular, we use the Kaplan-
Meier estimators for all survival functions and pΓips, tq “ pSipsqpSiptqni şs^t0 rYip1 ´ ∆pΛiqs´1dpΛi for each covariance
function Γi, where Yi is the number at risk process and pΛi is the Nelson-Aalen estimator for the cumulative hazard matrix
in group i. Note that if ∆pΛipuq “ 1, we also have pSipuq “ 0 in which case we let pΓips, tq “ 0 if s ě u or t ě u. We
denote the resulting covariance matrix estimator by pVN .
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Lemma 2. Under the asymptotic regime (4) we have the consistency pVN pÝÑ V.
All of the developed convergence results are now utilized to find the most natural test statistic. First note that the
asymptotic covariance matrix V is singular since 11d
?
Npp ´ pq ” 0, whence rpVq ď d ´ 1 follows. Furthermore, it
is not at all obvious whether the ranks of the Moore-Penrose inverse rppCpVNC1q`q converge in probability to the rank
rppCVC1q`q for a compatible contrast matrix C. Hence, the Wald-type statistic Np1C1pCpVNC1q`Cp is not suitable for
testing Hp0 pCq : Cp “ 0: Its asymptotic behaviour is unclear and, hence, there is no reasonable choice of critical values.
Instead, we utilize a statistic that does not rely on the uncertain convergence of ranks of generalized inverses. This
leads us to the survival version of the so-called ANOVA-rank-type statistic
FN pTq “ N
trpTpVN qp1Tp, (5)
whereT “ C1pCC1q`C is the unique projection matrix onto the column space ofC. Below we analyze both, its asymptotic
behaviour under null hypotheses of the from Hp0 pCq : Cp “ 0 and under the corresponding alternative hypotheses
HpapCq : Cp ‰ 0.
Theorem 2. Assume the asymptotic regime (4) and that trpTVq ą 0.
a) Under Hp0 pCq and as N Ñ 8, we have FN pTq dÝÑ χ “ W1E1dTEdW{trpTVq which is non-degenerate and
non-negative with Epχq “ 1.
b) Under HpapCq and as N Ñ8, we have FN pTq pÝÑ 8.
As the distribution of χ depends on unknown quantities (cf. Theorem 1) the test statistic FN pTq in (5) is no asymptotic
pivot. To nevertheless obtain proper critical values which lead to asymptotically exact inference procedures we next
propose and study a resampling approach.
4 Inference via Multiplier Bootstrap
In this section, we apply suitably tailored multiplier bootstrap techniques in order to approximate the small sample distri-
bution of FN pTq. To this end, we consider the situation under Hp0 pCq in which case we may expand
FN pTq “ N
trpTpVN q pp´ pq1Tpp´ pq “ NtrpTpVN q pdφS ¨ ppS´ Sqq1E1d T EdpdφS ¨ ppS´ Sqq ` opp1q,
where pS is the vectorial aggregation of all Kaplan-Meier estimators pS1, . . . , pSd. First, we replace the martingale residuals,
that are attached to the Kaplan-Meier estimators, with independent centered random variables which have approximately
the same variance. In particular, we replace
?
NppSi ´ Siq with
pSptq ¨ ?N niÿ
k“1
Gik
ż t
0
rpYipuq ´∆NipuqqYipuqs´1{2dNikpuq;
cf. Dobler (2017) for a similar wild bootstrap Greenwood-type correction for tied survival data. Here we utilized the
usual counting process notation (Andersen et al., 1993): Nik indicates whether the event of interest already took place for
individual k in group i. The wild bootstrap multipliers Gik, i “ 1, . . . , ni, i “ 1, . . . , d, are i.i.d. with zero mean and unit
variance and also independent of the data. In Bluhmki et al. (2018a,b) a similar multiplier resampling approach is applied
to Nelson-Aalen and Aalen-Johansen estimators in one- and two-sample problems.
In a next step toward the construction of a wild bootstrap statistic, we replace dφS with dφpS. Let us denote the thus
obtained wild bootstrap version of
?
NdφS ¨ ppS ´ Sq by W˚N . Conditionally on the data, this d2-variate random vector
is for large N approximately normally distributed and its limit distribution coincides with that of W; see the proof of
Theorem 3 below for details.
Finally, a wild bootstrap version FN˚ pTq of FN pTq requires that we also use a consistent wild bootstrap-type estimator
trpTV˚N q of trpTpVN q. It is found by replacing the estimators pΓi with
Γi˚ ps, tq “ pSipsqpSiptq ni niÿ
k“1
G2ik
ż s^t
0
dNik
pYi ´∆NiqYi .
Its conditional consistency was argued in Dobler (2017) and a sufficient condition for this is EpG411q ă 8. These wild
bootstrap-type variance estimators also have the nice interpretation of optional variation processes of the wild bootstrapped
Kaplan-Meier estimators (Dobler, 2017). Hence, the resulting wild bootstrap version of FN pCq is
FN˚ pTq “ 1trpTV˚N qW
˚
N
1E1d T EdW
˚
N .
The following conditional central limit theorem ensures the consistency of this resampling approach.
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Theorem 3. Assume EpG411q ă 8 and that the conditions of Theorem 2 hold. Conditionally on pXik, δikq, i “
1, . . . , d, k “ 1, . . . , ni, we have for all underlying values of p
FN pTq˚ dÝÑ χ “ W1E1dTEdW{trpTVq
in probability as N Ñ8.
We would like to stress that the limit distribution coincides with that of FN pTq under Hp0 pCq. For the wild boot-
strap version FN pTq˚, however, the convergence result holds under both, the null and the alternative hypothesis, i.e. its
conditional distribution always approximates the correct null distribution of the test statistic.
We conclude the theoretical part of this article with a presentation of deduced inference procedures for the effect sizes
p. To this end, let cN˚,α denote the p1´αq-quantile, α P p0, 1q, of the conditional distribution of FN˚ pTq given the data. In
practice, this quantile is approximated via simulation by repeatedly generating sets of the wild bootstrap multipliers Gki.
Corollary 1. Under the assumptions of Theorem 3, the test
ϕN “ 1tFN pTq ą cN˚,αu
is asymptotically exact and consistent. That is, EpϕN q Ñ α ¨ 1Hp0 pCq ` 1HpapCq as N Ñ8.
Now, let r be the number of columns of C1 and denote by c1, . . . , cr its column vectors. The presentation of a
simultaneous confidence region for the contrasts c1`p, ` “ 1, . . . , r, in Corollary 2 below will be done in an implicit
manner.
Corollary 2. Under the assumptions of Theorem 3, an asymptotically exact p1´αq-confidence ellipsoid for the contrasts
c1` p, ` “ 1, . . . , r, is given by
CE “ CEN,1´αpCq “
!
v P Rr : pCp´ vq1pCC1q`pCp´ vq ď trpTpVN q
N
cN˚,α
)
.
That is, P pCp P CEq Ñ 1´ α as N Ñ8.
5 Simulations
In this section, we assess the small sample properties of the test ϕN as proposed in Corollary 1.
5.1 Behaviour under null hypotheses
We first focus on its type I error control with respect to
• various kinds of contrast matrices
• and different censoring intensities.
Design and Sample Sizes. For ease of presentation we restrict ourselves to a design with d “ 6 groups with different sam-
ple size layouts: we considered small samples in a balanced design with n1 “ pn1, . . . , n6q1 “ p10, 10, 10, 10, 10, 10q1
and two unbalanced designs with n2 “ pn1, . . . , n6q1 “ p10, 12, 14, 10, 12, 14q1 and n3 “ p10, 12, 14, 14, 10, 12q1, re-
spectively. To obtain designs with moderate to large sample sizes we increase these vectors component-wise by the factors
K P t2, 3, 5, 10u. Moreover, depending on the question of interest, we below distinguish between a one-way layout with
six independent groups and a 2ˆ 3 two-way design.
Censoring Framework. We considered exponentially distributed censoring random variables Ci1
ind„ Exppλiq with
the following vectors λ “ pλ1, . . . , λ6q1 of rate parameters: λ1 “ 0.4 ¨ 1, λ2 “ 0.5 ¨ 1, λ3 “ 2{3 ¨ 1, λ4 “
p0.4, 0.5, 2{3, 0.4, 0.5, 2{3q1, λ5 “ p0.4, 0.5, 2{3, 2{3, 0.5, 0.4q1, where 1 P R6 is the vector consisting of 1s only. Thus,
the first three settings correspond to equal censoring mechanisms with increased censoring rate from λ1 to λ3. The other
two (λ4 and λ5) lead to unequal censoring. By considering all 75 possible combinations, many possible effects of cen-
soring and sample size assignments are analyzed. For example, in the set-up with n2, K “ 10 and λ4, larger sample sizes
are matched with a stronger censoring rate in an unbalanced design.
Contrast Matrices and Null Hypotheses. We simulated the true significance level of the tests for the null hypotheses
Hp0 pCq : Cp “ 0 for two designs and different contrast matrices of interest:
In case of a one-way design with d “ 6 groups we were interested in the null hypotheses of ‘no group effect’ or ‘equality
of all treatment effects’ Hp0 pC1q : tC1p “ 0u “ tp1 “ ¨ ¨ ¨ “ p6u. This may be described by considering the matrix
C1 “ P6, where here and below Pd “ Id ´ Jd{d ” Id ´ 1d11d{d denotes the d-dimensional centering matrix.
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Next, we consider a 2 ˆ 3 two-way layout with two factors A (with two levels) and B (with three levels). This is incor-
porated in Model (1) by setting d “ a ¨ b “ 2 ¨ 3 “ 6 and splitting up the index i into two indices i1 “ 1, 2 (for the levels
of factor A) and i2 “ 1, 2, 3 (for the levels of factor B). Thus, we obtain survival times Ti1i2k, k “ 1, . . . , ni1i2 , and
corresponding nonparametric concordance effects pi1i2 . More complex factorial designs can be incorporated similarly. In
this 2ˆ 3 set-up we are now interested in testing the null hypotheses of
(A) ‘No main effect of factor A’: Hp0 pC2,Aq : tC2,Ap “ 0u “ tp¯1¨ “ p¯2¨u,
(B) ‘No main effect of factor B’: Hp0 pC2,Bq : tC2,Bp “ 0u “ tp¯¨1 “ p¯¨2 “ p¯¨3u and
(AB) ‘No AˆB interaction effect’: Hp0 pC2,ABq : tC2,ABp “ 0u “ tpi1i2 ´ p¯i1¨ ´ p¯¨i2 ` p¯¨¨ “ 0 for all i1, i2u,
where p¯i1¨, p¯¨i2 and p¯¨¨ denote the means over the dotted indices. In particular, the corresponding contrast matrices are
given by C2,A “ P2 b 13J3,C2,B “ 12J2 b P3, and C2,AB “ P2 b P3, where b indicates the Kronecker product.
Survival Distributions. For ease of presentation we only considered a rather challenging scenario, where the groups
follow different survival distributions. In particular, we simulated
(G1) a lognormal distribution with meanlog parameter 0 and sdlog parameter 0.2726 for the first group,
(G2) a Weibull distribution with scale parameter 1.412 and shape parameter 1.1 for the second group,
(G3) a Gamma-distribution with scale parameter 0.4 and shape parameter 2.851 for the third group and
(G4-G6) mixing distributions of all pair combinations of the first three survival functions for the last three groups.
The first three survival functions are illustrated in Figure 1. We note that preliminary simulations for more crude scenar-
ios with identical survival distributions in all groups exhibited a much better type-I-error control of our testing procedure
(results not shown). Anyhow, the parameters of the above distributions were chosen in such a way that the nonparamet-
ric concordance effects of all groups are equal, i.e. pi “ 0.5 for all i “ 1, . . . , 6 (one-way) and pi1i2 “ 0.5 for all
i1 “ 1, 2; i2 “ 1, 2, 3 (two-way), respectively. Thus, all considered null hypotheses are true. We would like to stress
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Figure 1: Survival functions underlying the first three simulated sample groups.
that the case of continuously distributed survival times corresponds to an infinite-dimensional problem and is thus more
difficult than the discrete case. For example, the simulation study in Dobler (2017) confirms this observation in a related
problem: the convergence rate of the actual coverage probabilities of confidence bands to the nominal confidence level
is much faster the more discretely distributed the survival data is. Moreover, to make the simulation scenario even more
challenging, we considered the situation with infinite τ to also get an indication of the functionality of the test in this case.
Simulations. We chose as wild bootstrap multipliers centered unit Poisson variables because a formal Edgeworth expan-
sion and two simulation studies in Dobler et al. (2017) indicate that those have theoretical and practical advantages over
the common choice of standard normal multipliers. We chose the nominal level α “ 5% and conducted each test 10,000
times for K “ 1, 2, 3 and 5,000 times for K “ 5, 10 because of the massively increasing computational complexity for
large samples. Each test was based on critical values that were found using 1,999 wild bootstrap iterations. All simula-
tions were conducted with the help of the R computing environment (R Development Core Team, 2010–2015).
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Results. The true type-I-error results for the four different null hypotheses are shown in Table 1 (left panel: one-way
for Hp0 pC1q and right panel: two-way for Hp0 pC2,Aq) and Table 2 (two-way for Hp0 pC2,Bq in the left and Hp0 pC2,ABq in
the right panel). It is apparent that all simulated levels are elevated for the smallest sample sizes (K “ 1), especially
for the one-way test: here almost all type I error probabilities are between 13.0% and 17.7%. For the two-way tests,
these probabilities are mainly between 8.1% and 11.7% in this case (K “ 1). On the one hand, this is due to the rel-
atively strong censoring rates: for λ “ 0.4, the censoring probabilities across all sample groups are between 33% and
37% (found by simulating 100,000 censoring and survival time random variables each), for λ “ 0.5, these probabilities
range from 39.5% to 41.5%, and for λ “ 2{3, they even reach values between 48.5% and 49%; resulting in only 5 to
7 uncensored observations per group. On the other hand, not to restrict the time horizon in inferential procedures about
survival functions appears to slightly slow down the convergence of type I error probabilities to the nominal level as the
sample size increases; see Dobler (2018) for similar findings in the context of confidence bands for unrestricted survival
functions. However, the error probabilities recover for samples of double size (i.e. between 20 and 28) already: in the
one-way design, these error rates drop to mainly 8.2%´ 9.9%, and in all two-way tests, we even achieve rates of mainly
6.1% ´ 8%. If the sample sizes are tripled (i.e. between 30 and 42), most of the type I error probabilities are between
7% ´ 8% (one-way) or 5.2% ´ 6.9% (two-way). In case of the sample size factor K “ 5, all results are only slightly
liberal, and for K “ 10 (i.e. sample sizes between 100 and 140), we see that the nominal level is well attained.
n λ / K 1 2 3 5 10
λ1 14.7 8.8 7.2 6.4 5.7
λ2 16.6 9.3 7.7 6.3 5.7
n1 λ3 19.7 11.0 8.6 6.6 5.8
λ4 17.7 9.9 7.7 6.1 5.9
λ5 17.4 9.5 7.8 6.7 6.3
λ1 13.0 7.9 6.7 5.9 5.7
λ2 13.9 8.4 7.1 6.9 5.4
n2 λ3 16.5 9.1 7.8 6.2 5.8
λ4 14.9 8.5 7.3 6.0 5.6
λ5 14.6 9.0 6.8 6.3 5.6
λ1 12.2 8.2 7.1 6.0 5.2
λ2 13.7 8.6 7.0 6.1 5.3
n3 λ3 17.7 9.3 7.6 6.8 5.9
λ4 14.8 8.8 7.7 6.3 5.9
λ5 14.1 8.6 7.2 6.3 5.9
n λ / K 1 2 3 5 10
λ1 9.0 6.3 6.0 5.7 5.4
λ2 9.0 6.7 6.0 5.6 4.6
n1 λ3 10.5 7.0 6.3 5.9 5.6
λ4 10.1 6.7 6.1 5.7 5.7
λ5 9.4 6.2 5.8 5.6 5.0
λ1 7.7 6.3 5.8 5.3 5.9
λ2 8.1 6.3 6.0 6.0 5.3
n2 λ3 9.7 6.8 6.4 5.0 5.4
λ4 8.2 6.3 6.2 5.9 5.4
λ5 8.9 6.7 6.2 5.4 5.1
λ1 7.8 6.3 6.0 5.6 4.9
λ2 8.5 6.2 5.5 5.3 5.0
n3 λ3 9.2 6.9 6.5 5.6 5.1
λ4 8.4 6.1 6.1 5.8 4.5
λ5 8.2 6.7 5.7 6.0 5.7
Table 1: Simulated type I error probabilities in a one-way layout (left) and in a two-way design for main effect A (right)
with sample size factor K.
n λ / K 1 2 3 5 10
λ1 10.0 7.2 6.4 6.2 6.0
λ2 11.4 7.7 6.7 5.9 4.9
n1 λ3 13.4 8.0 6.9 5.9 5.8
λ4 12.2 7.6 6.9 6.1 5.9
λ5 12.1 7.5 6.7 5.9 5.6
λ1 9.5 6.6 6.1 6.0 5.0
λ2 10.2 7.4 6.5 6.0 5.5
n2 λ3 11.6 7.8 6.6 5.6 5.7
λ4 10.4 7.0 6.4 5.5 6.1
λ5 10.2 7.1 6.2 5.9 5.4
λ1 9.5 7.2 5.8 5.2 5.2
λ2 9.6 6.8 6.3 5.4 5.6
n3 λ3 11.6 7.4 6.9 6.2 5.6
λ4 9.9 7.4 6.2 6.5 5.4
λ5 9.7 7.2 6.4 5.7 5.0
n λ / K 1 2 3 5 10
λ1 10.1 7.2 6.3 5.7 5.3
λ2 11.2 7.2 6.2 5.9 5.1
n1 λ3 13.3 8.5 7.0 6.5 5.5
λ4 11.6 7.8 6.6 6.1 5.3
λ5 11.6 7.7 6.4 5.9 5.6
λ1 9.2 6.6 5.9 6.2 5.3
λ2 9.8 6.9 6.6 5.4 5.7
n2 λ3 11.7 7.5 6.4 5.8 5.4
λ4 9.8 6.8 6.4 5.2 5.0
λ5 10.8 7.1 6.2 5.8 5.6
λ1 8.3 6.6 6.3 5.2 5.1
λ2 9.6 6.9 5.9 5.8 5.7
n3 λ3 11.2 7.6 6.4 5.3 5.8
λ4 10.4 6.9 5.8 5.4 4.7
λ5 9.8 6.8 5.5 5.5 5.7
Table 2: Simulated type I error probabilities in a two-way design for main effect B (left) and for interaction effect AB
(right) with sample size factor K.
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5.2 Behaviour under shift alternatives
In addition to the simulations of the previous subsection, we also conducted a small power simulation of the above tests.
For the alternative hypotheses, we considered a shift model: taking the same six basic survival and censoring functions as
in the first set of simulations, we shift all survival and censoring times of the first sample group by δ P t0.1, 0.2, . . . , 1u. In
this way, we maintain the same censoring rates as before and the distance to the null hypotheses is gradually increased: for
growing δ ą 0, we obtain a growing relative effect p1 ą 0.5 (one-way) and p11 ą 0.5 (two-way), respectively. For each
of the above considered contract matrices, C1,C2,A,C2,B ,C2,AB , we conducted one set of simulations with different
unbalanced sample sizes and censoring rate combinations. For each set-up, we increased the sample sizes by the factors
K “ 1, 3, 5. The results are displayed in Figure 2.
We see that, even for the smallest sample sizes (between 10 and 14), the power of the two-way testing procedures
increase to 0.5 or 0.6 as the shift parameter approaches 1. For larger samples sizes the theoretically proven consistency is
apparent. In comparison, the one-way test has a much higher power: For the undersized case (K “ 1) it already reaches a
power of 0.8 while for moderate to larger sample sizes the power is almost 1 for shift parameters δ ě 0.5. In comparison
to the two-way procedure its superior power is, however, partially paid at the price of its pronounced liberality; especially
for small sample sizes.
All in all, the simulations confirm that all tests have a satisfactory power with increasing sample size and/or shift
parameter while maintaining a reasonable control of the nominal level for sample sizes of 30 to 42 already.
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Figure 2: Power functions for shift alternatives for different null hypotheses: in the one-way layout (sample sizes n “
K ¨ n2, censoring rates λ “ λ5), in the two-way layout for main effect A (n “ K ¨ n3, λ “ λ4), for main effect B
(n “ K ¨ n3, λ “ λ2), and for the interaction effect (n “ K ¨ n2, λ “ λ4), K “ 1, 3, 5. The nominal significance level is
α “ 5% (- - -).
6 Data example
We illustrate the developed theory on a dataset from a colon cancer study (Moertel et al., 1990). Considering the patients in
Stage C, that is, there had been metastases to regional lymph nodes, the data consist of eligible 929 patients suffering from
colon cancer. Survival (measured in days) was the primary endpoint of the study. We focus on the two factors ‘gender’ and
‘treatment’ (with three levels) to obtain a crossed 2ˆ 3 survival design which is in line with a setting from our simulation
study. In particular, there were 315 patients in the observation group, 310 others were treated with levamisole, and 304
received levamisole, combined with fluorouracil. Levamisole was originally used as an anthelmintic drug and fluorouracil
(5-FU) is a medicine to treat various types of cancer. The patients in the study had been randomized into one of these three
treatment groups. Also, there were nearly as many women (445) as men (484) involved in the study. Figure 3 depicts the
Kaplan-Meier estimates of the survival probabilities for each treatment ˆ sex subgroup. We refer to Moertel et al. (1990)
for more details about the study. The dataset is freely accessible via the R command data(colonCS) after having
loaded the package condSURV (Meira-Machado and Sestelo, 2016a,b).
The aim is now to investigate the presence of main or interaction effects of treatment and gender. As there are
several ties in the data (roughly 16%; see Appendix C for details) and we do not want to impose specific distributional
assumptions, we focus on the nonparametric concordance effects. To this end, we first have to choose a proper τ . From
our retrospective view, the most reasonable choice is found by determining for each group the minimal observed censoring
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Figure 3: Kaplan-Meier estimator for male and female subgroups, discriminated further according to treatment: obs =
observation, lev = levamisole treament, lev+fluo = combined levamisole and fluorouracil treatment. The end time in the
plot is τ = day 2173.
time that exceeds all observed survival times in that group. We call these censoring times “terminal times”. Then, τ is
set to be the minimal terminal time. In doing so, the group with that minimum terminal time does not benefit nor does it
suffer from having the earliest terminal time when compared to the other groups.
The first block in Table 3 shows the sample sizes of all subgroups. In the present data example, the minimal terminal
time is τ “ 2173; see the second block of Table 3. In view of the sample sizes and the censoring rates given in the third
block of Table 3, we compare the present dataset with the simulation set-ups in Section 5: a similarly strong censorship
is obtained for λ3 and comparable sample sizes n P r100, 140s for the choice K “ 10. Thus, judging from the rightmost
columns of Tables 1 and 2, we find it is safe to assume actual type I error probabilities of about 5.1% to 5.9% of the
proposed nonparametric one- and two-way survival tests.
sample size terminal time censoring rate effect size
treatment male female male female male female male female
observation 166 149 2800 2562 47.6 51.0 0.475 0.483
levamisole 177 133 2915 2173 47.5 52.6 0.459 0.501
levamisole plus fluorouracil 141 163 2726 2198 68.8 55.2 0.581 0.501
Table 3: For each subgroup: sample size, smallest censoring time (in days) exceeding the largest survival time, censoring
rate (in %) after taking the minimum of each event time and τ “ 2173, and nonparametric concordance effects. Columns:
sex, row: treatments.
We tested the data in one- and two-factorial set-ups and chose α “ 5% as the significance level. As in the simulation
study, we used B “ 1,999 bootstrap iterations for each test. For the tests in the two-factorial model, we considered the
null hypotheses corresponding to no main treatment effect, no main effect in sex, and no interaction effect between both.
The test results, by means of p-values, are shown in Table 4.
Null hypothesis Hp0 p¨q set-up p-value
Equality of all effects Hp0 pC1q one-factorial ă 0.001
No main effect in sex Hp0 pC2,Aq two-factorial 0.331
No main effect in treament Hp0 pC2,Bq two-factorial ă 0.001
No interaction effect Hp0 pC2,ABq two-factorial ă 0.001
Table 4: p-values of different hypothesis tests for the anaylsis of the colonCS data-set.
We found a significant indication against the equality of all d “ 6 groups (p-value ă 0.001) but this difference
between groups could not be inferred to result from a difference between the sexes (p-value “ 0.331). However, we
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found a significant treatment effect (p-value ă 0.001) as well as a significant interaction effect between treatment and sex
(p-value ă 0.001). The p-values in Table 4 have not been adjusted for a type I error multiplicity but it is obvious that the
results remain the same after an application of, say, the Bonferroni-Holm procedure.
Indeed, looking at the rightmost block of Table 3, we agree with the findings of the hypothesis tests: the gender
effect seems to be cancelled out if the treatment groups are combined, but within the male gender there seems to be a big
difference in the concordance effects (p1i2 P r0.459, 0.581s). Also, the interaction effect is apparent, as the female groups
do not seem to strongly benefit from any treatment (p2i2 P r0.483, 0.501s). On the other hand, the male groups exhibit
a worse than average survival fitness in the observation and the levamisole treatment group (p11 “ 0.475, p12 “ 0.459)
but a much better than average survival fitness for the combination treatment (p13 “ 0.581). Here the value p13 “ 0.581
roughly means that a randomly generated observation from this specific group survives a randomly generated observation
from the mean distribution of all groups with probability 58.1%. Taking another look at the Kaplan-Meier curves in
Figure 3, we immediately see that our concordance effects and the test outcomes make sense. We clearly see that there is
a big difference in the male survival probabilities (the combination treatment group is superior to the levamisole treatment
group which is in turn superior to the observation group) but there is not much of a difference between the female groups’
survival curves. Indeed, comparing the Kaplan-Meier curve of the pooled males’ survival times with that of the pooled
females’ times, we graphically find no evident main gender effect. The plot of both Kaplan-Meier estimators is shown in
Appendix C.
Finally, we relate our results to the original findings of Moertel et al. (1990) whose analyses involve the Cox pro-
portional hazards model and logrank tests. The authors also detected that “Therapy with levamisole plus fluorouracil
produced an unequivocal advantage over observation” and that levamisole alone did not produce a detectable effect. Fur-
thermore, they concluded from an exploratory subset analysis that the “levamisole-fluorouracil treatment appeared to have
the greatest advantage among male patients [...]”. This is exactly what we confirm in our analysis based on the nonpara-
metric two-factorial tests. However, Moertel et al. (1990) neither account for the present ties in the data (note that the Cox
regression postulates continuous outcomes) nor did they clearly stress the rather weak effect of the levamisole-fluorouracil
treatment for women. They just state that their “results show [...] striking contradictions to those of subset analyses re-
ported in the NCCTG study, in which levamisole plus fluorouracil was found to be most effective in reducing the risk of
recurrence among female patients [...]” among other subgroups of patients.
7 Discussion
We proposed novel nonparametric inference procedures for the analysis of factorial survival data that may be subject
to independent random right-censoring. Critical values are obtained from a multiplier wild bootstrap approach leading
to asymptotically valid tests and confidence regions for meaningful effect parameters. Thereby, the procedures do not
require any multiplicative or additive hazard structure nor specific distributional survival and censoring assumptions. In
particular, different group distributions are allowed and ties are accounted for accordingly. Moreover, different to the
nonparametric survival procedures of Akritas and Brunner (1997) and Akritas (2011), our methods are not only driven
towards hypothesis testing but also to uncertainty quantification of the underlying effect estimators. The latter can be
used to comprehensibly describe and infer main and interaction effects in general nonparametric factorial survival designs
with an arbitrary number of fixed factors. Together with a 1-1 connection with hazard ratios in proportional two-sample
designs (Bru¨ckner and Brannath, 2017), this makes the new methods appealing for practical purposes.
To investigate their theoretical properties, we rigorously proved central limit theorems of the underlying statistics and
consistency of the corresponding procedures. In addition, extensive simulations were conducted for one- and two-way
designs to also assess their finite sample properties in terms of power and type-I-error control. In case of small sample
sizes with less than 10 completely observed subjects per group, they revealed a liberal behaviour; especially for the one-
way testing procedure. However, for moderate to larger sample sizes the asymptotic results kicked in and the stated
theoretical results were recovered.
Finally, the methods were used to exemplify the analysis of survival data in a study about treatments for colon cancer
patient within a two-factorial survival design. As severe ties were present in the data, classical hazard based methods were
not directly applicable. In comparison, our newly proposed nonparametric methods provided a very decent alternative for
the analysis of such factorial survival designs without postulating any strict assumptions.
To allow for a straightforward application, it is planned to implement the procedure into an easy to use R-package. In
future research we will consider the case of stochastically ordered subgroups, for which a multiple testing algorithm could
be developed with the aim to detect significantly different collections of all subgroups: subgroups with no significant dif-
ferences in the nonparametric concordance effects may be combined to facilitate the interpretation of the outcomes and
to ultimately serve for the development of different, more personalized medicines, one for each new subgroup combina-
tion. Moreover, extensions of the current methodology to ordered alternatives or factorial designs obtained via stratified
sampling will be part of a practically useful consecutive testing procedure.
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Appendix
A Proofs
Proof of Lemma 1
The proof of this lemma is based on an extension of the results of Dobler and Pauly (2017). In that article it is shown that
the functional rφ : pBV r0, τ sq2 Ñ R, pf, gq ÞÑ ´ şτ
0
f˘puqdgpuq is Hadamard-differentiable in functions of bounded
variation; see the proof of their Theorem 1 in the supplement to that article for more details. Hence, a similar result
transfers to the functional φ in the present article because φ is simply a multivariate aggregation of functionals of the same
type as rφ.
For the sake of completeness, we point out that the ppi´1qd`jqth entry of continuous and linear Hadamard-derivative
of φ at S is given by
pdφS ¨ hqi,j “
ż
h˘j dSi ´
ż
h˘i dSj , h “ ph1, . . . , hdq1 P pDr0, τ sqd,
if h1p0q “ ¨ ¨ ¨ “ hdp0q “ 0 which indeed is the case in the present application.
The other fundamental result that we require is the convergence of all normalized Kaplan-Meier estimators in dis-
tribution. It is well-known that
?
nippSi ´ Siq dÝÑ Ui on the Skorokhod space Dr0, τ s as ni Ñ 8 in the present
situation of independent right-censoring. Hence, due to the independence of all sample groups, it also follows that
diagpn1, . . . , ndq ¨ ppS´ Sq dÝÑ U on pDr0, τ sqd as minpn1, . . . , ndq Ñ 8.
Thus, after having added the multiplicative term
?
ni?
ni
in each component i “ 1, . . . , d, it follows by means of the
functional delta-method (cf. Theorem 3.9.4 in van der Vaart and Wellner, 1996) that
?
NpφppSq ´ φpSqq converges in
distribution as asserted.
Proof of Theorem 1
This convergence result follows immediately from Lemma 1 in combination with the continuous mapping theorem.
Proof of Lemma 2
It is well-known that each Kaplan-Meier estimator pSi and also each covariance function estimator pΓi is uniformly consis-
tent on r0, τ s for Si and on r0, τ s2 for Γi, respectively, i “ 1, . . . , d. Note here that due to the assumption P pTi1 ą τq ą 0
for all groups i the cumulative hazard functions are bounded on the interval of interest: Λipτq ă 8.
Since pVN is a continuous functional of these estimators, it follows from the continuous mapping theorem that the
matrix pVN is consistent for V. Likewise, we conclude that the estimator trpTpVN q is consistent for the trace trpTVq due
to continuity of the trace and linear maps.
Proof of Theorem 2
Again, the result essentially follows from the continuous mapping theorem as p ÞÑ p1Tp is a continuous map. Thus,
taking Lemma 2 into account, an application of Slutsky’s lemma reveals that
FN pCq dÝÑ χ
under Hp0 pCq as N Ñ8.
To show that χ has unit expectation, we note that the trace in the denominator of FN pCq accounts for the asymptotic
expectation of the quadratic form term: the expectation of a quadratic form X1AX for a random vector X with mean
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µ “ EpXq and covariance matrix Σ “ covpXq equals EpX1AXq “ trpAΣq ` µ1Aµ; cf. Corollary 3.2b.1 in Mathai and
Provost (1992). In our situation, where A “ T and Tp “ 0 under Hp0 pCq, the asymptotic expectation of Np1Tp under
Hp0 thus simplifies to trpTV q.
On the other hand, under the alternative hypothesis HpapCq, we have that
FN pTq “ N
trpTpVN qp1Tp “ NtrpTpVN q pp´ pq1Tpp´ pq ` NtrpTpVN q p2p´ pq1Tp.
The first term on the right-hand side converges in distribution to χ asN Ñ8. Of the second term, p2p´pq1Tp converges
to the positive number p1Tp. Thus, an application of Slutzky’s lemma yields that FN pTq pÑ8 as minnÑ8.
Proof of Theorem 3
This conditional central limit theorem holds because for each wild bootstrapped Kaplan-Meier estimator a conditional
central limit theorem holds separately; cf. Dobler (2017) who suggested a wild bootstrap resampling technique for
independently right-censored competing risks and survival data in the presence of ties. They are combined with the help
of the continuous mapping theorem and also with the consistency of the wild bootstrapped covariance estimators which
were shown in that same paper. Hence, the continuous mapping theorem implies that the conditional distribution of
FN˚ pTq given the data converges weakly in probability to the distribution of χ.
B Asymptotic Covariance Matrix V of
?
Npp´ pq
The covariance matrix V in Theorem 1 has the compact form
V “ 1
d2
dÿ
j“1
1
λj
ż ż
Γ˘˘j dSdS
1 `
ż ż
diag
´´ 1
λi
Γ˘˘i
¯d
i“1
¯
dS¯dS¯
´ 1
d
ż ż ´ 1
λi
Γ˘˘i
¯d
i“1
dS¯dS1 ´
´1
d
ż ż ´ 1
λi
Γ˘˘i
¯d
i“1
dS¯dS1
¯1
“ 1
d2
ż ż
11ddiagpλq´1Γ˘˘dSdS1 ` diagpλq´1
ż ż
diagpΓ˘˘qdS¯dS¯
´ 1
d
ż ż
diagpλq´1Γ˘˘dS¯dS1 ´
´1
d
ż ż
diagpλq´1Γ˘˘dS¯dS1
¯1
,
where Γ “ pΓiqi“1,...,d is the vectorial aggregation of asymptotic covariance functions of all Kaplan-Meier estimators.
C Additional Information on the Data Analysis
As stated in Section 6 of the paper there are severe ties present in the dataset. The explicit numbers of ties are presented
in Table 5 below. They show that 130 different observations occurred at least twice in the data set. In particular, only 781
different realizations are encountered among all 929 individuals leading to a ties rate of roughly 148{929 « 16%.
Observations that appear
once twice three times four times
651 115 12 3
Table 5: Number of ties in the data before we truncated at τ “ 2173 days
After choosing the truncation time τ “ 2173 days as described in the paper, the numbers of ties further increase as
illustrated in Table 6. This leads to a ties rate of approximately 439{929 « 47% in the final data analysis.
Observations that appear
once twice three times four times 361 times
421 59 7 2 1
Table 6: Number of ties in the data after we truncated at τ “ 2173 days
Finally, we present in Figure 4 the Kaplan-Meier curves with respect to gender, thus after a combination of all three male
subgroups and all three female subgroups. Even though the test for the main effect in gender was not detected to be
significant in the set-up with six subgroups, we found that gender became highly significant if the two-sample problem is
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considered (p-value ă 0.001). Indeed, in Figure 4 the survival times of male patients appear to be slightly stochastically
larger than those of the females. We thus see that the tests further gain in power when different subgroups are combined
as the involved sample sizes increase a lot. Of course, one should be careful with this new result because combining
subgroups may not always make sense. In this case, especially in view of the significant interaction effect between
treatment and gender, it could be reasonable to treat women differently than men.
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Figure 4: Kaplan-Meier curves for male (black) and female patients (red).
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